Stephan Sacher

Dipl.-Ing.

20012023

Research activity per year

Network

Günther Hannesschläger

  • RECENDT Research Center for Non Destructive Testing GmbH

External person

Michael Leitner

  • RECENDT Research Center for Non Destructive Testing GmbH

External person

Peter Kerschhaggl

  • EVK DI Kerschhaggl GmbH

External person

Kai Koch

  • Romaco Innojet GmbH

External person

Detlev Haack

  • Hermes Arzneimittel GmbH

External person

Andreas Buchsbaum

  • RECENDT Research Center for Non Destructive Testing GmbH

External person

Dirk Lochmann

  • Cremer Oleo GmbH & Co KG
  • IOI OLEO GmbH

External person

C. Oliver Kappe

  • NAWI Graz Geocenter
  • University of Graz
  • Research Center Pharmaceutical Engineering GmbH
  • Research Centre for Pharmaceutical Engineering
  • Karl-Franzens-Universität Graz, Institut für Chemie

External person

James DiNunzio

  • Merck & Co.

External person

Michael Dekner

  • Baxter AG
  • Takeda Manufacturing Austria AG

External person

Helmut Lammer

  • Österreichische Akademie der Wissenschaften

External person

Matthias Kerschhaggl

  • EVK DI Kerschhaggl GmbH

External person

Eva Roblegg

  • Research Center Pharmaceutical Engineering GmbH
  • University of Graz
  • BioTechMed-Graz
  • NAWI Graz Geocenter
  • Research Centre for Pharmaceutical Engineering

External person

Sowinski Sebastian

  • Sentronic GmbH

External person

Xin Feng

  • United States Food and Drug Administration

External person

Heinz Pichler

  • Research Center Pharmaceutical Engineering GmbH

External person

Rúben Martins Fraga

  • Research Centre for Pharmaceutical Engineering

External person

Ossi Korhonnen

  • University of Eastern Finland

External person

Markus Krumme

  • Sandoz GmbH

External person

Jarkko Ketolainen

  • University of Eastern Finland
  • European Consortium of Continuous Pharmaceutical Manufacturing

External person

Karl Lohner

  • University of Graz
  • University of Graz, Institute of Molecular Biosciences

External person

Robert W. Jr. Bondi

  • GlaxoSmithKline

External person

Huiquan Wu

  • United States Food and Drug Administration

External person

Elen Gartshein

  • Pfizer Inc.

External person

Anssi-Pekka Kartunnen

  • University of Eastern Finland

External person

Peter Sagmeister

  • Research Centre for Pharmaceutical Engineering
  • University of Graz

External person

Johannes G. Khinast

  • Research Center Pharmaceutical Engineering GmbH

External person

Gerhard Straka

  • G.L. Pharma GmbH

External person

Benjamin J. Glasser

  • Rutgers University, Department of Chemical and Biochemical Engineering
  • Rutgers, The State University of New Jersey

External person

Rainer Bastian

  • Driam Anlagenbau GmbH

External person

J. Breitenbach

  • Abbott Laboratory GmbH

External person

Thomas Fränkel

  • Driam Anlagenbau GmbH

External person

Daniel Koller

  • Karl-Franzens-Universität Graz, Institut für Physik

External person

Maxwell Korang-Yeboah

  • United States Food and Drug Administration

External person

Martin Vogt

  • Syntegon Technology GmbH

External person

H. Lammer

  • Österreichische Akademie der Wissenschaften

External person

Peter van der Wel

  • Hosokawa Micron B.V.

External person

G. Shlieout

  • Abbott Laboratory GmbH

External person

Aygün Doğan

  • Research Centre for Pharmaceutical Engineering

External person

Ch Rupp

  • Abbott Laboratory GmbH

External person

Benoît Igne

  • GlaxoSmithKline

External person

Josef Lingitz

  • PIA Automation Austria GmbH

External person

Jason D. Williams

  • Research Centre for Pharmaceutical Engineering
  • University of Graz

External person